M Byerly

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state
    Susan M Essock
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York City, USA
    Psychiatr Serv 60:1595-602. 2009
  2. pmc What's in a name? Let's keep asking
    Susan M Essock
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, Box 100, 1051 Riverside Drive, New York, NY 10032, USA
    Schizophr Bull 37:469-70. 2011
  3. pmc Effectiveness of switching from antipsychotic polypharmacy to monotherapy
    Susan M Essock
    New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 168:702-8. 2011

Research Grants

Collaborators

Detail Information

Publications3

  1. doi request reprint Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state
    Susan M Essock
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York City, USA
    Psychiatr Serv 60:1595-602. 2009
    ..This study sought to identify and characterize rates of clinically questionable prescribing in New York State...
  2. pmc What's in a name? Let's keep asking
    Susan M Essock
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, Box 100, 1051 Riverside Drive, New York, NY 10032, USA
    Schizophr Bull 37:469-70. 2011
    ..quot; This commentary suggests that, by respecting the preferences of those being named, clinicians may enhance engagement in treatment and demonstrate respect for people as individuals beyond the label of a disease...
  3. pmc Effectiveness of switching from antipsychotic polypharmacy to monotherapy
    Susan M Essock
    New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 168:702-8. 2011
    ..This randomized trial addressed the risks and benefits of staying on antipsychotic polypharmacy or switching to monotherapy...

Research Grants4

  1. EFFECTIVENESS OF SWITCHING ANTIPSYCHOTIC MEDICATIONS
    Susan Essock; Fiscal Year: 2003
    ..abstract_text> ..